Intervacc AB (publ)
SSE:IVACC.ST
Overview | Financials
Company Name | Intervacc AB (publ) |
Symbol | IVACC.ST |
Currency | SEK |
Price | 3.735 |
Market Cap | 282,875,081 |
Dividend Yield | 0% |
52-week-range | 3.315 - 12.681 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Jonas Sohlman |
Website | https://www.intervacc.se |
An error occurred while fetching data.
About Intervacc AB (publ)
Intervacc AB (publ), a biotechnology company, engages in the research and development of vaccines for bacterial infections in animal health care. The company devlops vaccines for horses, piglets, and dairy cows. It offers Strangvac, a vaccine for equine strangles. The company also markets and sells veterinary medicines; and provides diagnostic
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD